ID
27965
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: Screening. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (4)
- 11/30/17 11/30/17 -
- 12/7/17 12/7/17 -
- 12/7/17 12/7/17 -
- 1/4/18 1/4/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 7, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening Staging GOAL Trial B-cell Lymphoma NCT02499003
Screening Staging GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Staging
Description
Target Lesions
Description
Target lesion number
Data type
integer
Description
N = Node, O = Organ
Data type
integer
Description
specification localisation
Data type
text
Description
Side target lesion
Data type
text
Description
Size target lesion
Data type
integer
Measurement units
- mm
Description
Size target lesion
Data type
integer
Measurement units
- mm
Description
Target lesions: Sum of sizes
Description
Non-target lesions
Description
Localisation of non-target lesions
Description
N=Node, O=Organ
Data type
integer
Description
specification localisation non-target lesion
Data type
text
Similar models
Screening Staging GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM